![Benny Sorensen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Benny Sorensen
Chief Executive Officer at Hemab ApS
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Yvonne Greenstreet | M | 61 | 8 years | |
David Pyott | M | 70 | 9 years | |
John Maraganore | M | 60 |
Hemab ApS
![]() Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | 2 years |
Jørgen Søberg Petersen | M | - |
Hemab ApS
![]() Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | 4 years |
Christine Regan Lindenboom | F | 43 | 9 years | |
James Bilotta | M | - | 9 years | |
Marten Steen | M | 49 |
Hemab ApS
![]() Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | - |
Uyanga Chuluunbaatar | M | - |
Hemab ApS
![]() Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | - |
Linda Bain | F | 53 |
Hemab ApS
![]() Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | 2 years |
Dan Becker | M | 49 |
Hemab ApS
![]() Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | - |
Laura Tadvalkar | F | - |
Hemab ApS
![]() Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Johan Faber | M | - |
Hemab ApS
![]() Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | 4 years |
Yalonda Howze | F | 52 | 3 years | |
Eric S. Lander | M | 67 | 6 years | |
Theo Melas-Kyriazi | M | 64 | - | |
Raghu Kalluri | M | - | 4 years | |
Anne-Virginie Eggimann | M | 51 | - | |
Christopher Taylor | M | - | 3 years | |
Arianna Greco | M | - | - | |
Jason Haddock | M | 54 | 3 years | |
Avak Kahvejian | M | 48 | - | |
Karen Bernstein | M | 71 | - | |
Charles Cooney | M | 80 | - | |
Jonathan Michael Poole | M | 49 | - | |
Briggs Morrison | M | 65 | 3 years | |
Sriram Sathyanarayanan | M | 52 | 6 years | |
Susanna High | F | 56 | 9 years | |
Andrea DiFabio | F | 55 | - | |
Emmanuel Dulac | M | 55 | - | |
Richard Brudnick | M | 67 | 4 years | |
Al Boyle | M | - | 8 years | |
Oved Amitay | M | 58 | 4 years | |
Ariel Jasie | M | - | 3 years | |
Jae Kim | M | 54 | 4 years | |
Jeff Miller | M | - | 5 years | |
Nicole Barna | F | 50 | 4 years | |
Ajay Verma | M | - | - | |
Keith Pietropaolo | M | - | - | |
Noubar Afeyan | M | 61 | 2 years | |
Jennifer Wheler | M | - | - | |
Thomas Batchelor | M | - |
Hemab ApS
![]() Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | - |
Nereyda Garcia | F | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 33 | 78.57% |
Denmark | 9 | 21.43% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Benny Sorensen
- Personal Network